Health

PointClickCare Integrated Care Coordination Platform Applauded by Frost & Sullivan for Bridging the Communication Gap between Acute and Post-acute Healthcare Providers

Harmony by PointClickCare Enables Coordinated and Collaborative Care Delivery on a Secure and Integrated platform SANTA CLARA, California, Dec. 10, 2019 /PRNewswire/ -- Based on its recent analysis of the North American long-term and post-acute care (LTPAC) IT management market, Frost & Sullivan...

2019-12-10 22:00 1078

Breakthrough in Medical Electronics - A Novel Mixed & Augmented Reality Smart Glasses Surgical Navigation Solution

TAICHUNG, Dec. 10, 2019 /PRNewswire/ -- The mixed reality technology for surgery usually shown in the movies has now become a reality with the latest technological offering from theTaiwan-based company – Taiwan Main Orthopaedics Biotechnology and the branding name of medical devices is SURGLAS...

2019-12-10 16:34 889

Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting

SUZHOU, China, Dec. 10, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced that th...

2019-12-10 16:00 4069

CStone's anti-PD-L1 antibody demonstrates promising antitumor activity with a complete response rate of 33.3% and a good safety profile in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma

SUZHOU, China, Dec. 10, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) updated results from the CS1001-201 trial in a poster presentation at the 2019 American Society of Hematology (ASH) Annual Meeting. CS1001-201 trial is a single-arm, multicenter Phase II c...

2019-12-10 11:38 2629

Farrer Park Hospital Implements Non-Invasive Treatment for Prostate Cancer Patients in Singapore

SINGAPORE, Dec. 10, 2019 /PRNewswire/ -- Farrer Park Hospital is pleased to announce that it is the first inSouth East Asia to have implemented the Focal One® High-Intensity Frequency Ultrasound (HIFU) Robotic Technology, a non-invasive prostate cancer treatment, for patients with early-stage pro...

2019-12-10 08:15 3226

Townsville Hospital Treats First Australian Patient With Elekta Unity MR-Linac, a Transformative Approach to Precision Radiation Therapy

Ability to adapt daily treatment based on real-time MR imaging enables new approach to hard-to-treat cancers TOWNSVILLE, Australia, Dec. 10, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that Townsville Hospital inQueensland has treated the first patient in Australia using Elekta Unity ...

2019-12-10 08:13 6239

TechMah Medical & LimaCorporate Receive First 510k Approval for Smart SPACE Digital Technology

UDINE, Italy, Dec. 10, 2019 /PRNewswire/ -- LimaCorporate is pleased to announce the FDA510K approval for Smart SPACE Shoulder 3D Planner & 3D Positioner. Smart SPACE is an innovative digital platform developed by TechMah Medical thanks to collaboration with LimaCorporate, who entered into a mil...

2019-12-10 02:08 2194

Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies

SUZHOU, China and SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd ("Gracell"), a clinical-stage immune cell therapy company, today announced the progressive clinical outcomes for leading product candidates FasTCAR-19, Dual CAR-19-22, and Dual CAR-BCMA-19 at the American...

2019-12-09 22:00 1357

Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours

* First in-human Clinical Phase I study of intratumoural tigilanol tiglate (EBC-46) has been published in The Lancet's EBioMedicine journal; * An efficacious dose was achieved and a Maximum Tolerated Dose (MTD) was not reached, indicating tigilanol tiglate tolerability in humans; * Promising...

2019-12-09 21:01 1410

BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors

HANGZHOU, China, Dec. 9, 2019 /PRNewswire/ -- BJ Bioscience Inc. (the 'company') today announced that the first patient was successfully dosed on December 4, 2019 in the first-in-human (FIH) trial of the company's BJ-001 program at NEXT ONCOLOGY inSan Antonio, Texas.

2019-12-09 21:00 1440

CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody

SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company committed to discovering and developing a combined platform of Chimeric Antigen Receptor T (CAR-T) cell therapies and monoclonal antibodies for cancer, today announced that one of its leading d...

2019-12-09 18:00 3164

LPG SYSTEMS Unveils a Major Advancement: Irradiated Mastectomy Patients Can Benefit From Minimally Invasive Breast Reconstruction

NICE, France, Dec. 9, 2019 /PRNewswire/ -- A pilot study published in the Breast Journal shows the benefits of using Endermologie - a trademark of LPG SYSTEMS - in breast reconstruction after mastectomy and radiotherapy. This study included 65 women that had breast reconstruction with lipofilling...

2019-12-09 17:00 1632

Korean ophthalmologist Oh Jungwoo performed '25 sec LASEK' in public for the first time

SEOUL, South Korea, Dec. 6, 2019 /PRNewswire/ -- Dr. Oh Jungwoo from Eos Eye Center in Gangnam-gu, Korea, revealed '25 sec LASEK' surgery publicly by video. This is the first time the operation has been released to the public and it shows Dr. Oh's surgery on a patient's left eye with minimal corn...

2019-12-06 22:00 1327

PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided

HONG KONG, Dec. 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported thatChina's National Health Commission ("NHC") ...

2019-12-06 20:00 15332

CStone appoints seasoned pharmaceutical executive Shirley Zhao as the General Manager for Greater China and Head of Commercial

SUZHOU, China, Dec. 6, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced the appointment of Ms.Shirley Zhao to the position of General Manager forGreater China and Head of Commercial. In this position, Ms. Zhao will be responsible for the commerci...

2019-12-06 18:53 3706

CNN's 'Vital Signs with Dr. Sanjay Gupta' explores Traditional Chinese Medicine in Hong Kong

HONG KONG, Dec. 6, 2019 /PRNewswire/ -- There are few places in the world where modern and traditional intersect quite likeHong Kong, so what better place to explore the world of Traditional Chinese Medicine and ancient lifestyle practices. This month on CNN's 'Vital Signs' Dr.Sanjay Gupta travel...

2019-12-06 11:02 3268

Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-LAG-3 Monoclonal Antibody in China

SUZHOU, China, Dec. 6, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today a...

2019-12-06 08:00 12137

Neusoft Medical showcases new innovations at RSNA 2019

CHICAGO, Dec. 6, 2019 /PRNewswire/ -- RSNA 2019 marked Neusoft Medical's 20th year as an exhibitor. Neusoft Medical's diagnostic imaging solutions provide maximum value enabling healthcare providers to provide better care to their patients.  Neusoft Medical keeps exploring new innovations to meet...

2019-12-06 03:24 4245

Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann to Step Down, Longtime Foundation Executive Mark Suzman Appointed to Role

SEATTLE, Dec. 6, 2019 /PRNewswire/ -- Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann is stepping down after more than five years in the role. Bill and Melinda Gates have appointed Mark Suzman, the foundation's president of Global Policy & Advocacy and chief strategy officer, as the new ...

2019-12-06 02:41 3045

Chronolife Applauded by Frost & Sullivan for Flagship Predictive Health Analytics and Monitoring Smartwear

Chronolife's innovative T-shirt-based platform captures biometrics to track chronic conditions such as heart disease LONDON, Dec. 5, 2019 /PRNewswire/ -- Based on an in-depth analysis of the global predictive health analytics and monitoring market, Frost & Sullivan recognizesChronolife, a pionee...

2019-12-05 22:00 1019
1 ... 824825826827828829830 ... 848